☆ 4.6 Article

A Prospective Multicenter Comparison Study of Risk-adapted Ultrasound-directed and Magnetic Resonance Imaging-directed Diagnostic Pathways for Suspected Prostate Cancer in Biopsy-naive Men

EUROPEAN UROLOGY (2022)

Related references

Note: Only part of the references are listed.

Article Urology & Nephrology

Clinical implementation of pre-biopsy magnetic resonance imaging pathways for the diagnosis of prostate cancer

Bas Israel et al.

Summary: The study evaluated the outcomes of pre-biopsy MRI pathways in biopsy-naive men with suspicion of prostate cancer in routine clinical practice. The results showed that pre-biopsy MRI can be used as a decision tool without compromising cancer detection rates and with a higher biopsy avoidance rate. There were comparable cancer detection and complication rates between TR- and TP-MRDB.

BJU INTERNATIONAL (2022)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

PI-RADS Committee Position on MRI Without Contrast Medium in Biopsy-Naive Men With Suspected Prostate Cancer: Narrative Review

Ivo G. Schoots et al.

Summary: The increasing demand for diagnostic prostate MRI has raised concerns about access to qualified MRI equipment and experienced medical personnel. Solutions should aim to improve operational efficiency while maintaining diagnostic performance and quality. Strategies could involve implementing MRI without contrast medium or using a risk-based approach for protocol selection.

AMERICAN JOURNAL OF ROENTGENOLOGY (2021)

Add to Collection

Review Urology & Nephrology

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

Nicolas Mottet et al.

Summary: The 2020 EAU-EANM-ESTRO-ESUR-SIOG guidelines on screening, diagnosis, and treatment of localized prostate cancer summarize the most recent recommendations for clinical practice, including risk-adapted strategies, medical imaging utilization, biopsy techniques, patient classification, and treatment options. Recommendations include consideration of moderate hypofractionation for intermediate-risk patients and a combination of local treatment with long-term hormonal therapy for cN1 PCa patients.

EUROPEAN UROLOGY (2021)

Add to Collection

Article Oncology

Population-Based Prostate Cancer Screening With Magnetic Resonance Imaging or Ultrasonography The IP1-PROSTAGRAM Study

David Eldred-Evans et al.

Summary: In this cohort study, MRI with a score of 4 or 5 as a positive test result detected more clinically significant prostate cancer cases compared to PSA testing alone at 3 ng/mL or higher, without increasing unnecessary biopsies or overdiagnosing clinically insignificant cancer. Ultrasonography did not show superior performance to PSA testing alone.

JAMA ONCOLOGY (2021)

Add to Collection

Article Oncology

Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer A Phase 3 Randomized Clinical Trial

Laurence Klotz et al.

Summary: In men at risk for prostate cancer, magnetic resonance imaging followed by selected targeted biopsy is noninferior to initial systematic biopsy in detecting grade group 2 or greater cancers.

JAMA ONCOLOGY (2021)

Add to Collection

Article Urology & Nephrology

A comparison of prostate cancer prediction models in men undergoing both magnetic resonance imaging and transperineal biopsy: Are the models still relevant?

Paul Doan et al.

Summary: This study validated and compared the performance of the ERSPC-RC3/4, PBCG-RC, and van Leeuwen model in predicting high-grade prostate cancer in an Australian cohort undergoing TP biopsy. The ERSPC-RC3/4 demonstrated good discrimination and calibration, comparable to the van Leeuwen model. The van Leeuwen model showed the greatest net benefit from 10% risk onwards.

BJU INTERNATIONAL (2021)

Add to Collection

Review Urology & Nephrology

Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021

Hendrik Van Poppel et al.

Summary: The European Association of Urology in 2021 presented a risk-adapted strategy for early prostate cancer detection using PSA testing, risk calculators, and multiparametric magnetic resonance imaging. This approach aims to reduce overdiagnosis/overtreatment and improve quality of life by diagnosing significant cancer early.

EUROPEAN UROLOGY (2021)

Add to Collection

Article Oncology

Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial

Tobias Nordstrom et al.

Summary: This study compared traditional screening methods for prostate cancer with a diagnostic strategy combining blood-based risk prediction and MRI-targeted biopsies. The use of the Stockholm3 test was found to be non-inferior to PSA for the detection of clinically significant prostate cancer, while also detecting a similar number of low-grade cancers. Additionally, the combination of Stockholm3 with MRI-targeted biopsies led to higher detection rates of significant cancers and lower rates of low-grade cancers compared to standard screening methods.

LANCET ONCOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

MRI-Targeted or Standard Biopsy in Prostate Cancer Screening

Martin Eklund et al.

Summary: In the context of organized prostate cancer screening, MRI with targeted and standard biopsy was shown to be noninferior to standard biopsy for detecting clinically significant prostate cancer, while also resulting in less detection of clinically insignificant cancer.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Oncology

Assessing a Patient's Individual Risk of Biopsy-detectable Prostate Cancer: Be Aware of Case Mix Heterogeneity and A Priori Likelihood

Jan F. M. Verbeek et al.

Summary: Researchers developed a risk calculator to predict clinically significant prostate cancer on targeted and systematic biopsy. With the increasing use of multiparametric magnetic resonance imaging, the calculator is expected to be used in more men to provide accurate risk estimates.

EUROPEAN UROLOGY ONCOLOGY (2021)

Add to Collection

Review Urology & Nephrology

Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis

Frank-Jan H. Drost et al.

EUROPEAN UROLOGY (2020)

Add to Collection

Review Urology & Nephrology

Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2

Baris Turkbey et al.

EUROPEAN UROLOGY (2019)

Add to Collection

Article Urology & Nephrology

Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naive Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study

Marloes van der Leest et al.

EUROPEAN UROLOGY (2019)

Add to Collection

Article Urology & Nephrology

Negative Multiparametric Magnetic Resonance Imaging for Prostate Cancer: What's Next?

Valeria Panebianco et al.

EUROPEAN UROLOGY (2018)

Add to Collection

Article Medicine, General & Internal

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

V Kasivisvanathan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection

Article Oncology

Prostate Cancer Risk Assessment in Biopsy-naive Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy

Christophe K. Mannaerts et al.

EUROPEAN UROLOGY ONCOLOGY (2018)

Add to Collection

Article Urology & Nephrology

Prediction of Prostate Cancer: External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical Cohort

Maudy Gayet et al.

EUROPEAN UROLOGY FOCUS (2018)

Add to Collection

Article Andrology

Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome

Nuno Pereira-Azevedo et al.

TRANSLATIONAL ANDROLOGY AND UROLOGY (2018)

Add to Collection

Article Pathology

The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Definition of Grading Patterns and Proposal for a New Grading System

Jonathan I. Epstein et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)

Add to Collection

Article Urology & Nephrology

PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2

Jeffrey C. Weinreb et al.

EUROPEAN UROLOGY (2016)

Add to Collection

Article Urology & Nephrology

A Risk-Based Strategy Improves Prostate-Specific Antigen-Driven Detection of Prostate Cancer

Monique J. Roobol et al.

EUROPEAN UROLOGY (2010)

Add to Collection

© Peeref 2019-2024. All rights reserved.